Accutar Biotech stock

Accutar Biotech Stock

HealthTech

Looking to sell Accutar Biotech stock or options?

Founded: 2015Funding to Date: $207Mhttps://www.accutarbio.com

Accutar Biotech is a developer of bio-pharmaceutical technology aimed at speeding up drug discovery. The company employs computational drug design coupled with wet-lab validation, providing tools for side-chain flexible mode ligand docking, virtual screening, and prediction of drug ADME properties. This approach allows researchers to significantly cut down the time and expense typically associated with traditional drug discovery processes.

Investors Include:

Hedosophia, CMS Ventures, Karista (Paris), Alpha Protocol Ventures, YITU, Mirae Asset Capital, 5Y Capital, Yunfeng Capital, 3W Partners Capital, Newton BioCapital, Primavera Capital Group, CDH Investments, ZhenFund, IDG Capital, Primavera Venture Partners, Coatue Management.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more